UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31,2023
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number:001-41183
Welsbach Technology Metals Acquisition Corp.
(Exact name of registrant as specified in its charter)
| Delaware | 87-106702 |
|---|
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
|---|
| 160 S Craig Place Lombard, Illinois | 60148 |
|---|
| (Address of principal executive offices) | (Zip Code) |
|---|
Registrant’s telephone number, including area code:(217) 615-1216
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class: | Trading Symbol(s) | Name of Each Exchange on Which Registered: |
|---|
| Units, each consisting of one share of common stock, $0.0001 par value, and one right to receive one-tenth of one share of common stock | WTMAU | The Nasdaq Stock Market LLC |
|---|
| Common stock, $0.0001 par value per share | WTMA | The Nasdaq Stock Market LLC |
|---|
| Rights, each exchangeable into one-tenth of one share of common stock | WTMAR | The Nasdaq Stock Market LLC |
|---|
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes☐ No ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes☐ No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|---|
| Emerging growth company | ☒ | |
|---|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☒ No☐
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b).☐
As of September 29, 2023, the last business day of the registrant’s most recently completed third fiscal quarter, the aggregate market value of the registrant’s public shares, other than shares held by persons who may be deemed affiliates of the registrants was approximately $23,140,863. The closing price of the common stock on September 29, 2023 as reported on the Nasdaq Global Market was $10.65 per share.
As of April 16, 2024 there were 4,456,827 shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding.
| TABLE OF CONTENTS |
|---|
| Page |
|---|
| PART I | 1 | |
|---|
| Item 1. | Business. | 1 |
| Item 1A. | Risk Factors. | 17 |
| Item 1B. | Unresolved Staff Comments. | 19 |
| Item 1C. | Cybersecurity. | 19 |
| Item 2. | Properties. | 19 |
| Item 3. | Legal Proceedings. | 19 |
| Item 4. | Mine Safety Disclosures. | 19 |
| PART II | 20 | |
|---|
| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities. | 20 |
| Item 6. | Reserved. | 21 |
| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations. | 21 |
| Item 7A. | Quantitative and Qualitative Disclosures about Market Risk. | 29 |
| Item 8. | Financial Statements and Supplementary Data. | 30 |
| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. | 30 |
| Item 9A. | Controls and Procedures. | 30 |
| Item 9B. | Other Information. | 30 |
| Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. | 30 |
| PART III | 31 | |
|---|
| Item 10. | Directors, Executive Officers and Corporate Governance. | 31 |
| Item 11. | Executive Compensation. | 35 |
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. | 36 |
| Item 13. | Certain Relationships and Related Transactions, and Director Independence. | 37 |
| Item 14. | Principal Accountant Fees and Services. | 40 |
| PART IV | | 41 | |
|---|
| Item 15. | Exhibit and Financial Statement Schedules. | 41 |
i
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Report (as defined below), including, without limitation, statements under “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” includes forward-looking statements within the meaning of Section 27A of the Securities Act (as defined below) and Section 21E of the Exchange Act (as defined below). These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our ability to consummate any acquisition or other business combination and any other statements that are not statements of current or historical facts. These statements are based on management’s current expectations, but actual results may differ materially due to various factors, including, but not limited to:
| ● | our ability to complete our initial business combination; |
| ● | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
| ● | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements; |
| ● | our potential ability to obtain additional financing to complete our initial business combination; |
| ● | the ability of our officers and directors to generate a number of potential acquisition opportunities; |
| ● | our pool of prospective target businesses; |
| ● | the ability of our officers and directors to generate a number of potential acquisition opportunities; |
| ● | our public securities’ potential liquidity and trading; |
| ● | the lack of a market for our securities; |
| ● | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; or |
| ● | our financial performance. |
The forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
Unless otherwise stated in this Report, or the context otherwise requires, references to:
| ● | “ASC 480” are to the Financial Accounting Standards Board Accounting Standards Codification Topic 480 “Distinguishing Liabilities from Equity;” |
| ● | “ASC” are to Accounting Standards Codification; |
| ● | “board of directors” or “board” are to the board of directors of the Company; |
| ● | “Business Combination” are to the Merger together with the other agreements and transactions in connection with Merger Agreement; |
ii
| ● | “Certifying Officers” to WTMA’s Chief Executive Officer and Chief Financial Officer; |
| ● | “Chardan” or the “Representative” are to Chardan Capital Markets, LLC, the representative of the underwriters; |
| ● | “common stock” are to shares of common stock, par value $0.0001 per share; |
| ● | “Continental” are to Continental Stock Transfer & Trust Company, trustee of our trust account (as defined |
| ● | “DGCL” are to the Delaware General Corporation Law; |
| ● | “DWAC System” are to the Depository Trust Company’s Deposit/Withdrawal At Custodian System; |
| ● | “Eighth Promissory Note” are to the promissory note issued by the Company on August 30, 2023 in the principal amount of $125,000 to the Sponsor in connection with the Extension and together with the First, Second, Third, Fourth, Fifth, Sixth, and Seventh Promissory Note, the “Promissory Notes”. |
| ● | “Exchange Act” are to the Securities Exchange Act of 1934, as amended; |
| ● | “Extension” are to the extended time period of time for the Company to complete a business combination under its amended and restated certificate of incorporation; |
| ● | “Fifth Promissory Note” are to the promissory note issued by the Company on May 30, 2023 in the principal amount of $125,000 to the Sponsor in connection with the Extension and together with the First, Second, Third, and Fourth Promissory Note, the “Promissory Notes”. |
| ● | “First Promissory Note” are to the promissory note issued by the Company on September 30, 2022 in the principal amount of $772,769 to the Sponsor in connection with the Extension; |
| ● | “Fourth Promissory Note” are to the promissory note issued by the Company on April 30, 2023 in the principal amount of $125,000 to the Sponsor in connection with the Extension and together with the First, Second, and Third Promissory Note, the “Promissory Notes”.“Founder Shares” or “founder shares” are to the 1,931,922 shares of common stock held or controlled by our insiders (as defined below); |
| ● | “GAAP” are to the accounting principles generally accepted in the United States of America; |
| ● | “Holders” are to the Sponsor and certain other investors party to the Business Combination, who will enter into the Registration Right Agreements; |
| ● | “IASB” are to the International Accounting Standards Board; |
| ● | “IFRS” are to the International Financial Reporting Standards, as issued by the International Accounting Standards Board; |
| ● | “initial business combination” are to a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses; |
| ● | “initial public offering” are to the initial public offering that was consummated by the Company on December 30, 2021; |
| ● | “Initial Stockholders” or “initial stockholders” are to the Company’s Sponsor, officers and directors and other holders of Founders Shares; |
| ● | “insiders” are to our officers, directors, sponsor and any other holder of our founder shares; |
iii
| ● | “Investment Company Act” are to the Investment Company Act of 1940, as amended; |
| ● | “JOBS Act” are to the Jumpstart Our Business Startups Act of 2012; |
| ● | “management” or our “management team” are to our officers and directors; |
| ● | “March Extensions” are to the extended time period of an additional six months from March 30, 2023 to September 30, 2023 for the Company to complete a business combination under its amended and restated certificate of incorporation; |
| ● | “Merger Agreement” are to the Agreement and Plan of Merger by and among WTMA, Merger Sub and WaveTech dated as of October 31, 2022 attached hereto as Annex A; |
| ● | “Merger Sub” are to WTMA Merger Subsidiary Corp., a Delaware corporation; |
| ● | “Nasdaq” are to the Nasdaq Stock Market; |
| ● | “Over-allotment” or “over-allotment” are to the partial exercise of the option on January 14, 2022 by the underwriters; |
| ● | “Over-allotment Units” or “over-allotment units” are to the 227,686 additional Units purchased by the underwriters pursuant to the partial exercise of the option on January 14, 2022; |
| ● | “PCAOB” are to the Public Company Accounting Oversight Board (United States); |
| ● | “private rights” are to the rights included within the private units purchased by our sponsor in the private placement and any rights included within private units issued upon conversion of working capital loans as described herein; |
| ● | “private shares” are to the shares of common stock included within the private units purchased by our sponsor in the private placement and any additional shares of common stock included within private units issued upon conversion of working capital loans as described herein; |
| ● | “Private Placement Units” or “private placement units” are to the Units that were sold in private placements simultaneously with the closing of the IPO; |
| ● | “private placement” are to a private placement of our units consummated in connection with our initial public offering; |
| ● | “private units” are to the 352,054 units we sold privately to Welsbach Acquisition Holdings LLC, our sponsor, in connection with our initial public offering; |
| ● | “public shares” are to shares of common stock which were sold as part of the units in our initial public offering (whether they were purchased in our initial public offering or thereafter in the open market) and references to “public stockholders” are to the holders of our public shares, including our insiders to the extent our insiders purchase public shares, provided that their status as “public stockholders” exists only with respect to such public shares; |
| ● | “Redemption Rights” are to the rights of the public stockholders to demand redemption of their public stock for cash. |
| ● | “Registration Statement” are to the Form S-1 filed with the SEC December 21, 2021 (File No. 333-261467), as amended; |
| ● | “rights” or “public rights” are to the rights which were sold as part of the units in our initial public offering; |
iv
| ● | “Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002; |
| ● | “Second Promissory Note” are to the promissory note issued by the Company on December 30, 2022 in the principal amount of $772,769 to the Sponsor in connection with the Extension and together with the First Promissory Note, the “Promissory Notes”. |
| ● | “SEC” are to the U.S. Securities and Exchange Commission; |
| ● | “Securities Act” are to the Securities Act of 1933, as amended; |
| ● | “Seventh Promissory Note” are to the promissory note issued by the Company on July 30, 2023 in the principal amount of $125,000 to the Sponsor in connection with the Extension and together with the First, Second, Third, Fourth, Fifth, and Sixth Promissory Note, the “Promissory Notes”. |
| ● | “Sixth Promissory Note” are to the promissory note issued by the Company on June 30, 2023 in the principal amount of $125,000 to the Sponsor in connection with the Extension and together with the First, Second, Third, Fourth, and Fifth Promissory Note, the “Promissory Notes”. |
| ● | “Special Meeting” are to the special meeting of the WTMA stockholders in lieu of its 2023 annual meeting; |
| ● | “Sponsor Persons” are to Daniel Mamadou, Christopher Clower, John Stanfield, Dr. Ralph Welpe, Emily King, Matthew Mrozinski and Sergey Marchenko; |
| ● | “Sponsor Support and Lock-up Agreement” are to that certain Support and Lock-up Agreement, dated October 31, 2022, by and among the Sponsor, the Sponsor Persons, WTMA and WaveTech; |
| ● | “sponsor” are to Welsbach Acquisition Holdings LLC; |
| ● | “Sponsors” or “sponsors” are to the Sponsor and the persons set forth in the Sponsor Support and Lock-up Agreement; |
| ● | “Subject Stockholder Shares” are to any shares of Company common stock owned by Company Stockholders immediately after the Closing; |
| ● | “Subject Sponsor Shares” are to any shares of Company common stock owned by one of the Sponsors immediately after the Closing; |
| ● | “Talaxis” are to Talaxis Group, the Techmetals division within the Noble Group; |
| ● | “Third Promissory Note” are to the promissory note issued by the Company on March 30, 2023 in the principal amount of $125,000 to the Sponsor in connection with the Extension and together with the First and Second Promissory Note, the “Promissory Notes”. |
| ● | “Treasury” are to the U.S. Department of the Treasury; |
| ● | “trust account” are to the U.S.-based trust account in which an amount of $77,276,860 from the net proceeds of the sale of the units (as defined below) in the initial public offering and private placement units was placed following the closing of the initial public offering and the partial exercise of the underwriter’s over-allotment option; |
| ● | “UHY” are to UHY LLP, our independent registered public accounting firm; |
| ● | “Underwriting Agreement” are to that certain underwriting agreement, dated December 27, 2021, by and between the Company and Chardan Capital Markets, LLC, as representative of the several underwriters; |
| ● | “units” are to the units sold in our initial public offering, which consist of one public share and one public right; and |
| ● | “we,” “us,” “Company” or “our Company,” “Welsbach,” or “WTMAC” are to Welsbach Technology Metals Acquisition Corp. |
| ● | “Working Capital Loans” are to loans to the Company funds by certain of the Company’s officers and directors in order to finance transaction costs in connection with a Business Combination. |
v